Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 102INDUSTRY 51NIH 17OTHER_GOV 6NETWORK 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 66Breast 65Other hematologic neoplasm 59Genitourinary 58CNS 52Gastrointestinal 51Thoracic 40Sarcoma 29Plasma cell 28Gynecologic 22Head & Neck 19Dermatologic 17Tumor-Agnostic 15Other solid neoplasm 12Myeloid 11Endocrine 4Other neoplasm 3Classical hematology 3Other 2NET 2

Conditions

Neuroendocrine Tumors 2Pheochromocytoma 1Nephroma, Mesoblastic 1Neoplasms 1Myeloproliferative Disorders 1Melanoma 1Lymphoproliferative Disorders 1Ganglioneuroma 1Desmoid Tumors 1Central Nervous System Neoplasms 1Carcinoma in Situ 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × NET × 1 year × Clear all
NCT02402244 2026-05-05

Project: Every Child for Younger Patients With Cancer

Children's Oncology Group

Recruiting
75,000 enrolled
CNSDermatologicEndocrineLymphoidMyeloidNETSarcoma

Carcinoma in Situ, Ganglioneuroma, Lymphoproliferative Disorders, Melanoma, Myeloproliferative Disorders, Neoplasms, Pheochromocytoma, Central Nervous System Neoplasms, Nephroma, Mesoblastic, Desmoid Tumors, Neuroendocrine Tumors

NCT06345079 2025-08-14

STOPNET

Australasian Gastro-Intestinal Trials Group

Phase 2 Recruiting
78 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡